2 Healthcare Stocks That Will Be Worth More Than Pfizer by the End of 2026
Pfizer‘s (NYSE: PFE) shares have been southbound for the last three years. And unfortunately for the company, it…
Bank of America Says These 2 Healthcare Stocks Are Top Ideas for 1Q26
As 2026 gets rolling, it’s only natural to want to find the best stocks to boost the portfolio…
Glomerulonephritis Market Projected to Surge by 2034 with Rising Demand for Targeted Therapies
The glomerulonephritis market is witnessing steady growth driven by the increasing prevalence of chronic kidney diseases and improved…
Reporter’s Notebook: The Overdue Breakout for Gene Therapy and Gene Editing
As gene editing enters a new era, leaders discuss Baby KJ’s implications for families, science, and industry. (Left…